glp 1 suicide The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw FDA asks for removal of

Nutritional supplements and herbal medicines for women with polycystic ovary syndrome

(Lippincott Williams & Wilkins, 1999)

3-carboxy-2-hydroxy-n,n,n-trimethyl-1-propanaminium Hydroxide, Inner Salt 28

If beneficiaries want coverage it looks like out-of-pocket cost may not be capped and will be borne by the patient, not the insurer. GLP1 drugs can cost thousands of dollars per year per patient, and Medicares current coverage rules generally prohibit paying for weightloss drugs unless Congress makes a specific exception

This man-made peptide comes from a protein in the stomach

This is where the expertise of a healthcare professional becomes invaluable